BACKGROUND: In populations with high prevalences of diabetes and obesity, estimating glomerular filtration rate (GFR) by using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation may predict cardiovascular disease (CVD) risk better than by using the Modification of Diet in Renal Disease (MDRD) Study equation. STUDY DESIGN: Longitudinal cohort study comparing the association of GFR estimated using either the CKD-EPI or MDRD Study equation with incident CVD outcomes. SETTING & PARTICIPANTS: American Indians participating in the Strong Heart Study, a longitudinal population-based cohort with high prevalences of diabetes, CVD, and CKD. PREDICTOR: Estimated GFR (eGFR) predicted using the CKD-EPI and MDRD Study equations. OUTCOMES: Fatal and nonfatal cardiovascular events, consisting of coronary heart disease, stroke, and heart failure. MEASUREMENTS: The association between eGFR and outcomes was explored in Cox proportional hazards models adjusted for traditional risk factors and albuminuria; the net reclassification index and integrated discrimination improvement were determined for the CKD-EPI versus MDRD Study equations. RESULTS: In 4,549 participants, diabetes was present in 45%; CVD, in 7%; and stages 3-5 CKD, in 10%. During a median of 15 years, there were 1,280 cases of incident CVD, 929 cases of incident coronary heart disease, 305 cases of incident stroke, and 381 cases of incident heart failure. Reduced eGFR (<90 mL/min/1.73 m2) was associated with adverse events in most models. Compared with the MDRD Study equation, the CKD-EPI equation correctly reclassified 17.0% of 2,151 participants without incident CVD to a lower risk (higher eGFR) category and 1.3% (n=28) were reclassified incorrectly to a higher risk (lower eGFR) category. LIMITATIONS: Single measurements of eGFR and albuminuria at study visits. CONCLUSIONS: Although eGFR based on either equation had similar associations with incident CVD, coronary heart disease, stroke, and heart failure events, in those not having events, reclassification of participants to eGFR categories was superior using the CKD-EPI equation compared with the MDRD Study equation.
BACKGROUND: In populations with high prevalences of diabetes and obesity, estimating glomerular filtration rate (GFR) by using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation may predict cardiovascular disease (CVD) risk better than by using the Modification of Diet in Renal Disease (MDRD) Study equation. STUDY DESIGN: Longitudinal cohort study comparing the association of GFR estimated using either the CKD-EPI or MDRD Study equation with incident CVD outcomes. SETTING & PARTICIPANTS: American Indians participating in the Strong Heart Study, a longitudinal population-based cohort with high prevalences of diabetes, CVD, and CKD. PREDICTOR: Estimated GFR (eGFR) predicted using the CKD-EPI and MDRD Study equations. OUTCOMES: Fatal and nonfatal cardiovascular events, consisting of coronary heart disease, stroke, and heart failure. MEASUREMENTS: The association between eGFR and outcomes was explored in Cox proportional hazards models adjusted for traditional risk factors and albuminuria; the net reclassification index and integrated discrimination improvement were determined for the CKD-EPI versus MDRD Study equations. RESULTS: In 4,549 participants, diabetes was present in 45%; CVD, in 7%; and stages 3-5 CKD, in 10%. During a median of 15 years, there were 1,280 cases of incident CVD, 929 cases of incident coronary heart disease, 305 cases of incident stroke, and 381 cases of incident heart failure. Reduced eGFR (<90 mL/min/1.73 m2) was associated with adverse events in most models. Compared with the MDRD Study equation, the CKD-EPI equation correctly reclassified 17.0% of 2,151 participants without incident CVD to a lower risk (higher eGFR) category and 1.3% (n=28) were reclassified incorrectly to a higher risk (lower eGFR) category. LIMITATIONS: Single measurements of eGFR and albuminuria at study visits. CONCLUSIONS: Although eGFR based on either equation had similar associations with incident CVD, coronary heart disease, stroke, and heart failure events, in those not having events, reclassification of participants to eGFR categories was superior using the CKD-EPI equation compared with the MDRD Study equation.
Authors: B V Howard; T K Welty; R R Fabsitz; L D Cowan; A J Oopik; N A Le; J Yeh; P J Savage; E T Lee Journal: Diabetes Date: 1992-10 Impact factor: 9.461
Authors: E T Lee; T K Welty; R Fabsitz; L D Cowan; N A Le; A J Oopik; A J Cucchiara; P J Savage; B V Howard Journal: Am J Epidemiol Date: 1990-12 Impact factor: 4.897
Authors: Elisa T Lee; Barbara V Howard; Wenyu Wang; Thomas K Welty; James M Galloway; Lyle G Best; Richard R Fabsitz; Ying Zhang; Jeunliang Yeh; Richard B Devereux Journal: Circulation Date: 2006-06-12 Impact factor: 29.690
Authors: Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh Journal: Am J Kidney Dis Date: 2007-12 Impact factor: 8.860
Authors: B V Howard; E T Lee; L D Cowan; R B Devereux; J M Galloway; O T Go; W J Howard; E R Rhoades; D C Robbins; M L Sievers; T K Welty Journal: Circulation Date: 1999-05-11 Impact factor: 29.690
Authors: Marina Scavini; Christine A Stidley; Susan S Paine; Vallabh O Shah; Francesca Tentori; Arlene Bobelu; Thomas K Welty; Jean W MacCluer; Philip G Zager Journal: Clin J Am Soc Nephrol Date: 2007-04-18 Impact factor: 8.237
Authors: B V Howard; E T Lee; L D Cowan; R R Fabsitz; W J Howard; A J Oopik; D C Robbins; P J Savage; J L Yeh; T K Welty Journal: Am J Epidemiol Date: 1995-08-01 Impact factor: 4.897
Authors: Xilin Yang; Ronald C Ma; Wing-Yee So; Gary T Ko; Alice P Kong; Christopher W Lam; Chun-Shun Ho; Clive S Cockram; Vivian C Wong; Peter C Tong; Juliana C Chan Journal: Cardiovasc Diabetol Date: 2007-12-02 Impact factor: 9.951
Authors: Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey Journal: JAMA Date: 2012-05-09 Impact factor: 56.272
Authors: Katherine A Moon; Yiyi Zhang; Eliseo Guallar; Kevin A Francesconi; Walter Goessler; Jason G Umans; Lyle G Best; Barbara V Howard; Richard B Devereux; Peter M Okin; Ana Navas-Acien Journal: Environ Pollut Date: 2018-05-26 Impact factor: 8.071
Authors: Lene Ryom; Jens D Lundgren; Mike Ross; Ole Kirk; Matthew Law; Philippe Morlat; Eric Fontas; Colette Smit; Christoph A Fux; Camilla I Hatleberg; Stéphane de Wit; Caroline A Sabin; Amanda Mocroft Journal: J Infect Dis Date: 2016-08-02 Impact factor: 5.226
Authors: Laura Y Zheng; Jason G Umans; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Karen Bandeen-Roche; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien Journal: Epidemiology Date: 2015-07 Impact factor: 4.822
Authors: Laura Y Zheng; Jason G Umans; Maria Tellez-Plaza; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien Journal: Am J Kidney Dis Date: 2012-11-09 Impact factor: 8.860
Authors: Miranda Jones Spratlen; Mary V Gamble; Maria Grau-Perez; Chin-Chi Kuo; Lyle G Best; Joseph Yracheta; Kevin Francesconi; Walter Goessler; Yasmin Mossavar-Rahmani; Meghan Hall; Jason G Umans; Amanda Fretts; Ana Navas-Acien Journal: Food Chem Toxicol Date: 2017-05-04 Impact factor: 6.023
Authors: Farrah J Mateen; Maria Grau-Perez; Jonathan S Pollak; Katherine A Moon; Barbara V Howard; Jason G Umans; Lyle G Best; Kevin A Francesconi; Walter Goessler; Ciprian Crainiceanu; Eliseo Guallar; Richard B Devereux; Mary J Roman; Ana Navas-Acien Journal: Environ Res Date: 2017-05-26 Impact factor: 6.498
Authors: Miranda J Spratlen; Maria Grau-Perez; Lyle G Best; Joseph Yracheta; Mariana Lazo; Dhananjay Vaidya; Poojitha Balakrishnan; Mary V Gamble; Kevin A Francesconi; Walter Goessler; Shelley A Cole; Jason G Umans; Barbara V Howard; Ana Navas-Acien Journal: Am J Epidemiol Date: 2018-08-01 Impact factor: 4.897
Authors: V Saroja Voruganti; Nora Franceschini; Karin Haack; Sandra Laston; Jean W MacCluer; Jason G Umans; Anthony G Comuzzie; Kari E North; Shelley A Cole Journal: Eur J Hum Genet Date: 2013-12-04 Impact factor: 4.246
Authors: Astrid M Suchy-Dicey; Ying Zhang; Sterling McPherson; Katherine R Tuttle; Barbara Howard; Jason Umans; Dedra S Buchwald Journal: Kidney360 Date: 2021-01-28